Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

The article argues that the Vanguard Total International Stock ETF (VXUS) presents a compelling investment opportunity due to a significant valuation gap between international and U.S. stocks. While international stocks have underperformed the S&P 500 by a wide margin over the past decade, they now trade at substantially lower valuations, suggesting potential for outperformance over the next 10 years.

Why I Think This Vanguard ETF Will Beat the S&P 500 Over the Next 10 Years

Swing & day trader
Tweets are my opinion only and not a recommendation to buy or sell any security.
I don't Have any subservice/ WhatsApp group /Telegram group!

HODOR

USC Pharmacy Alumni, Full Time Investor. My tweets are a general reflection of my Investments and not a recommendation. Please do your own due diligence.

Novartis AG ADR (NVS) Stock Price, Analysis & Trade Signals